ADC Therapeutics SA
ADCT- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001771910
No open-market purchases or sales by ADC Therapeutics SA insiders were filed in the last 90 days; 113 institutions reported holding it in 13F filings for Q2 2026, worth $86.3M in total; no superinvestor holds it.
Q3 2024 vs. Q2 2024
How the institutions holding ADC Therapeutics SA changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Of which not filed for Q3 2024 | Q3 2024 | Change |
|---|---|---|---|---|
| Holders | 74 | 2 | 77 | +5 |
| Shares | 51.8M | 3.57M | 54.9M | +6.62M (+13.7%) |
| Value | $163.7M | $11.3M | $172.9M | +$20.5M (+13.4%) |
2 institutions that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (19)
Institutions that held ADC Therapeutics SA at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| BlackRock, Inc. | 4,399,134 | $13.9M | 0.00% |
| Siren, L.L.C. | 1,163,461 | $3.66M | 0.18% |
| Wellington Management Group LLP | 168,557 | $531.0K | 0.00% |
| Bryn Mawr Trust Co | 100,000 | $315.0K | 0.01% |
| Squarepoint Ops LLC | 75,392 | $237.5K | 0.00% |
| FMR LLC | 53,042 | $167.1K | 0.00% |
| Mirae Asset Global ETFs Holdings Ltd. | 38,274 | $120.6K | 0.00% |
| SG Americas Securities, LLC | 26,657 | $84.0K | 0.00% |
| AQR Capital Management LLC | 22,107 | $69.6K | 0.00% |
| Readystate Asset Management LP | 17,039 | $53.7K | 0.00% |
| ProShare Advisors LLC | 15,366 | $48.4K | 0.00% |
| Intech Investment Management LLC | 12,998 | $40.9K | 0.00% |
| Russell Investments Group, Ltd. | 7,546 | $23.8K | 0.00% |
| Tower Research Capital LLC (TRC) | 4,646 | $14.6K | 0.00% |
| Cornerstone Planning Group LLC | 276 | $831 | 0.00% |
| Sterling Capital Management LLC | 132 | $416 | 0.00% |
| Nisa Investment Advisors, LLC | 115 | $362 | 0.00% |
| Northwestern Mutual Wealth Management Co | 36 | $113 | 0.00% |
| CWM, LLC | 24 | $0 | 0.00% |
Sold out (14)
Institutions that held ADC Therapeutics SA at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| Artal Group S.A. | 1,018,461 | $3.22M |
| Affinity Asset Advisors, LLC | 474,744 | $1.50M |
| Atom Investors LP | 322,289 | $1.02M |
| Miracle Mile Advisors, LLC | 84,496 | $267.0K |
| Susquehanna International Group, LLP | 54,126 | $171.0K |
| Citadel Advisors LLC | 41,433 | $130.9K |
| Acadian Asset Management LLC | 16,454 | $51.0K |
| Caption Management, LLC | 15,925 | $50.3K |
| Palumbo Wealth Management LLC | 13,270 | $41.9K |
| Nomura Holdings Inc | 10,000 | $31.6K |
| State of Wyoming | 6,221 | $19.7K |
| Global Retirement Partners, LLC | 200 | $632 |
| Federation des caisses Desjardins du Quebec | 20 | $63 |
| Gradient Investments LLC | 11 | $35 |
Not filed for Q3 2024 yet (2)
Institutions that held ADC Therapeutics SA at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| BlackRock Inc. | 3,554,742 | $11.2M |
| Susquehanna Fundamental Investments, LLC | 10,355 | $32.7K |